Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_assertion type Assertion NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_head.
- NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_assertion wasGeneratedBy ECO_0000203 NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_provenance.
- NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_assertion wasDerivedFrom befree-20140225 NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_provenance.
- NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_assertion SIO_000772 23799135 NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_provenance.
- NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_assertion evidence source_evidence_literature NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_provenance.
- NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_assertion description "[The E6-RHDV-VLP-PADRE was administered therapeutically for the treatment of a pre-existing TC-1 tumour and was delivered with antibodies either to deplete regulatory T cells (anti-CD25) or to block T cell suppression mediated through CTLA-4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306423.RAsrNoeGY9PuQubwj1Dvjm6Omd33K_GJMU8-vNNvIJnGM130_provenance.